# FDA 483 - Glenmark Pharmaceuticals Inc USA - June 16, 2025

Source: https://www.keypedia.com/records/483/glenmark-pharmaceuticals-inc-usa/facf78be-e9f5-44d2-ad1f-a2fccd330cdc

> FDA 483 for Glenmark Pharmaceuticals Inc USA on June 16, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Glenmark Pharmaceuticals Inc USA
- Inspection Date: 2025-06-16
- Product Type: other
- Office Name: Division of Information Disclosure Policy
- Summary: Unable to generate a concise summary as the provided document content is empty and contains no information regarding an FDA 483 inspection. The document only indicates page numbers without any textual content related to a company name, inspection dates, main violations, regulatory framework, or required actions. Please provide the full text of the inspection report to allow for accurate summarization.

## Related Officers

- [Sandrea A. Munroe](https://www.keypedia.com/people/sandrea-a-munroe/e7808ea0-c592-4547-a54c-fce152f8ffc7)
- [Damaris V. Hernandez](https://www.keypedia.com/people/damaris-v-hernandez/39abff1e-06bc-4c95-9268-5ab5bc43f6b9)
- [Homero W. Aguilar](https://www.keypedia.com/people/homero-w-aguilar/fbc95655-a1a8-456f-a09a-7bc8a213a786)
- [Luis P. Torres](https://www.keypedia.com/people/luis-p-torres/995f71e1-b7b8-4c30-9d53-2127b01f8d47)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-inc-usa/beae020e-8475-49b9-89b8-b84056f15461

Office: https://www.keypedia.com/offices/division-of-information-disclosure-policy/0c0ebf49-2470-4002-937b-bb098361ac5f